| RS2547824218 |
ATP7B
|
Health Risk |
Pathogenic |
Wilson disease, Wilson disease |
| RS2547824726 |
ATP7B
|
Health Risk |
Conflicting classifications of pathogenicity |
Wilson disease, Wilson disease |
| RS2547824925 |
ATP7B
|
Health Risk |
Likely pathogenic |
Wilson disease, Wilson disease |
| RS2547825080 |
ATP7B
|
Health Risk |
Pathogenic |
Wilson disease, Wilson disease |
| RS2547825108 |
ATP7B
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Wilson disease |
| RS2547825208 |
ATP7B
|
Health Risk |
Pathogenic |
Wilson disease, Wilson disease |
| RS2547825848 |
ATP7B
|
Health Risk |
Likely pathogenic |
Wilson disease, Wilson disease |
| RS2547825885 |
ATP7B
|
Health Risk |
Pathogenic |
Wilson disease, Wilson disease |
| RS2547826484 |
ATP7B
|
Health Risk |
Likely pathogenic |
Wilson disease, Wilson disease |
| RS2547826614 |
ATP7B
|
Health Risk |
Likely pathogenic |
Wilson disease, Wilson disease |
| RS2547826878 |
EIF2B1
|
Health Risk |
Pathogenic |
— |
| RS2547828012 |
EIF2B1
|
Health Risk |
Pathogenic |
— |
| RS2547828052 |
SDCCAG8
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome 16, Senior-Loken syndrome 7 |
| RS2547829389 |
CPLANE1
|
Health Risk |
Pathogenic |
— |
| RS2547832232 |
PCDH15
|
Health Risk |
Pathogenic |
— |
| RS2547832439 |
PCDH15
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 23, Autosomal recessive nonsyndromic hearing loss 23 |
| RS2547832670 |
PCCA
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2547833048 |
PCDH15
|
Health Risk |
Pathogenic |
— |
| RS2547833210 |
PCDH15
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 23, Autosomal recessive nonsyndromic hearing loss 23 |
| RS2547833358 |
PCDH15
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1D, Usher syndrome type 1D |
| RS2547844200 |
KCNC2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 103, Developmental and epileptic encephalopathy 103 |
| RS2547851230 |
SDCCAG8
|
Health Risk |
Likely pathogenic |
Focal segmental glomerulosclerosis, Focal segmental glomerulosclerosis |
| RS2547851268 |
TMEM126A
|
Health Risk |
Pathogenic |
— |
| RS2547854950 |
CPLANE1
|
Health Risk |
Pathogenic |
— |
| RS2547855732 |
CPLANE1
|
Health Risk |
Pathogenic |
— |
| RS2547859493 |
SDCCAG8
|
Health Risk |
Pathogenic |
Senior-Loken syndrome 7, Bardet-Biedl syndrome 16 |
| RS2547866979 |
ADK
|
Health Risk |
Pathogenic |
— |
| RS2547869345 |
MEF2C
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with hypotonia, stereotypic hand movements |
| RS2547872368 |
PCDH15
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 23, Autosomal recessive nonsyndromic hearing loss 23 |
| RS2547872482 |
PCDH15
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 1D, Usher syndrome type 1F |
| RS2547884822 |
PPP1R12A
|
Health Risk |
Likely pathogenic |
Genitourinary and/or brain malformation syndrome, Genitourinary and/or brain malformation syndrome |
| RS2547885939 |
SDCCAG8
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome 16, Senior-Loken syndrome 7 |
| RS2547886035 |
SDCCAG8
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome 16, Senior-Loken syndrome 7 |
| RS2547886067 |
SDCCAG8
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2547886688 |
VPS13C
|
Health Risk |
Pathogenic |
— |
| RS2547891117 |
VPS13C
|
Health Risk |
Pathogenic |
— |
| RS2547891931 |
PPP1R12A
|
Health Risk |
Pathogenic |
PPP1R12A-related disorder, PPP1R12A-related disorder |
| RS2547891962 |
PPP1R12A
|
Health Risk |
Pathogenic |
Genitourinary and/or brain malformation syndrome, Genitourinary and/or brain malformation syndrome |
| RS2547893717 |
PPP1R12A
|
Health Risk |
Pathogenic |
PPP1R12A-related disorder, Genitourinary and/or brain malformation syndrome |
| RS2547893982 |
VPS13C
|
Health Risk |
Pathogenic |
— |
| RS2547899469 |
PCCA
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2547899474 |
PCCA
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2547899480 |
PCCA
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2547899507 |
PCCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2547899687 |
PCCA
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2547899695 |
PCCA
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2547899803 |
PCCA
|
Health Risk |
Pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2547899927 |
PCCA
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2547899930 |
PCCA
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2547899934 |
PCCA
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2547903295 |
CPLANE1
|
Health Risk |
Likely pathogenic |
Orofaciodigital syndrome type 6, Orofaciodigital syndrome type 6 |
| RS2547907419 |
VPS13C
|
Health Risk |
Likely pathogenic |
Autosomal recessive early-onset Parkinson disease 23, Autosomal recessive early-onset Parkinson disease 23 |
| RS2547907937 |
VPS13C
|
Health Risk |
Likely pathogenic |
Autosomal recessive early-onset Parkinson disease 23, Autosomal recessive early-onset Parkinson disease 23 |
| RS2547923716 |
PCCA
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2547923770 |
PCCA
|
Health Risk |
Pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2547945307 |
MAPK8IP3
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with or without variable brain abnormalities, NEDBA |
| RS2547945615 |
MAPK8IP3
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with or without variable brain abnormalities, NEDBA |
| RS2547946899 |
GNPTAB
|
Health Risk |
Pathogenic |
Pseudo-Hurler polydystrophy, Pseudo-Hurler polydystrophy |
| RS2547948030 |
TAC3
|
Health Risk |
Likely pathogenic |
— |
| RS2547948106 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS2547949681 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS2547949758 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS2547951445 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS2547951708 |
ADAMTS17
|
Health Risk |
Pathogenic |
— |
| RS2547951809 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Pseudo-Hurler polydystrophy, Mucolipidosis type II |
| RS2547951831 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS2547951848 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Pseudo-Hurler polydystrophy, Mucolipidosis type II |
| RS2547951882 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Pseudo-Hurler polydystrophy, Mucolipidosis type II |
| RS2547952059 |
PPP1R12A
|
Health Risk |
Likely pathogenic |
Genitourinary and/or brain malformation syndrome, Genitourinary and/or brain malformation syndrome |
| RS2547952219 |
PPP1R12A
|
Health Risk |
Likely pathogenic |
Genitourinary and/or brain malformation syndrome, Genitourinary and/or brain malformation syndrome |
| RS2547953413 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS2547953474 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Pseudo-Hurler polydystrophy, Mucolipidosis type II |
| RS2547953486 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS2547954157 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS2547954174 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Pseudo-Hurler polydystrophy, Pseudo-Hurler polydystrophy |
| RS2547954219 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS2547954355 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS2547954391 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Pseudo-Hurler polydystrophy, Mucolipidosis type II |
| RS2547954440 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS2547954482 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS2547954498 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS2547954945 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Pseudo-Hurler polydystrophy, Mucolipidosis type II |
| RS2547955024 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS2547956432 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS2547956448 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS2547956479 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS2547956692 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS2547956774 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS2547956808 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS2547956822 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis, Mucolipidosis |
| RS2547956895 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS2547956901 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Pseudo-Hurler polydystrophy, Mucolipidosis type II |
| RS2547956965 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Pseudo-Hurler polydystrophy, Mucolipidosis type II |
| RS2547956980 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS2547957057 |
BNC1
|
Health Risk |
Likely pathogenic |
Male infertility with azoospermia or oligozoospermia due to single gene mutation, Male infertility with azoospermia or oligozoospermia due to single gene mutation |
| RS2547957065 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Pseudo-Hurler polydystrophy, Mucolipidosis type II |
| RS2547957106 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS2547957136 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS2547957205 |
GNPTAB
|
Health Risk |
Likely pathogenic |
GNPTAB-related disorder, GNPTAB-related disorder |
| RS2547957216 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Pseudo-Hurler polydystrophy, Mucolipidosis type II |